{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:46:06Z","timestamp":1790711166194,"version":"4.1.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["209328\/Z\/17\/Z"],"award-info":[{"award-number":["209328\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Heterozygous <jats:italic>de novo<\/jats:italic> variants in <jats:italic>SAMD9<\/jats:italic> cause MIRAGE syndrome, a complex multisystem disorder involving Myelodysplasia, Infection, Restriction of growth, Adrenal hypoplasia, Genital phenotypes, and Enteropathy. The range of additional clinical associations is expanding and includes disrupted placental development, poor post-natal growth and endocrine features. Increasingly, milder phenotypic features such as hypospadias in small for gestational age (SGA) boys and normal adrenal function are reported. Some children present with isolated myelodysplastic syndrome (MDS\/monosomy 7) without MIRAGE features.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>We aimed to investigate: 1) the range of reported <jats:italic>SAMD9<\/jats:italic> variants, clinical features, and possible genotype-phenotype correlations; 2) whether SAMD9 disruption affects placental function and leads to pregnancy loss\/recurrent miscarriage (RM); 3) and if pathogenic variants are associated with isolated fetal growth restriction (FGR).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Published data were analyzed, particularly reviewing position\/type of variant, pregnancy, growth data, and associated endocrine features. Genetic analysis of <jats:italic>SAMD9<\/jats:italic> was performed in products of conception (POC, n=26), RM couples, (couples n=48; individuals n=96), children with FGR (n=44), SGA (n=20), and clinical Silver-Russell Syndrome (SRS, n=8), (total n=194).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>To date, <jats:italic>SAMD9<\/jats:italic> variants are reported in 116 individuals [MDS\/monosomy 7, 64 (55.2%); MIRAGE, 52 (44.8%)]. Children with MIRAGE features are increasingly reported without an adrenal phenotype (11\/52, 21.2%). Infants without adrenal dysfunction were heavier at birth (median 1515\u00a0g versus 1020\u00a0g; P &amp;lt; 0.05) and born later (median 34.5 weeks versus 31.0; P &amp;lt; 0.05) compared to those with adrenal insufficiency. In MIRAGE patients, hypospadias is a common feature. Additional endocrinopathies include hypothyroidism, hypo- and hyper-glycemia, short stature and panhypopituitarism. Despite this increasing range of phenotypes, genetic analysis did not reveal any likely pathogenic variants\/enrichment of specific variants in <jats:italic>SAMD9<\/jats:italic> in the pregnancy loss\/growth restriction cohorts studied.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>MIRAGE syndrome is more phenotypically diverse than originally reported and includes growth restriction and multisystem features, but without adrenal insufficiency. Endocrinopathies might be overlooked or develop gradually, and may be underreported. As clinical features including FGR, severe infections, anemia and lung problems can be non-specific and are often seen in neonatal medicine, SAMD9-associated conditions may be underdiagnosed. Reaching a specific diagnosis of MIRAGE syndrome is critical for personalized management.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.953707","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T06:09:42Z","timestamp":1660802982000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Emerging phenotypes linked to variants in SAMD9 and MIRAGE syndrome"],"prefix":"10.3389","volume":"13","author":[{"given":"Jenifer P.","family":"Suntharalingham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Del Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne E.","family":"Stalman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nita","family":"Solanky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Wakeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun E.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Achermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Buonocore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-8-92","article-title":"Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse","volume":"8","author":"Li","year":"2007","journal-title":"BMC Genomics"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02262-14","article-title":"SAMD9 is an innate antiviral host factor with stress response properties that can be antagonized by poxviruses","volume":"89","author":"Liu","year":"2015","journal-title":"J Virol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01122-15","article-title":"Identification of restriction factors by human genome-wide RNA interference screening of viral host range mutants exemplified by discovery of SAMD9 and WDR6 as inhibitors of the vaccinia virus K1L-C7L-mutant","volume":"6","author":"Sivan","year":"2015","journal-title":"MBio"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1515354112","article-title":"Structural basis for antagonizing a host restriction factor by C7 family of poxvirus host-range proteins","volume":"112","author":"Meng","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.08.011","article-title":"Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7","volume":"24","author":"Nagamachi","year":"2013","journal-title":"Cancer Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/J.BBRC.2014.10.054","article-title":"Overexpression of SAMD9 suppresses tumorigenesis and progression during non small cell lung cancer","volume":"454","author":"Ma","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1086\/508069","article-title":"A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis","volume":"79","author":"Topaz","year":"2006","journal-title":"Am J Hum Genet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701203","article-title":"Normophosphatemic familial tumoral calcinosis is caused by deleterious mutations in SAMD9, encoding a TNF-\u03b1 responsive protein","volume":"128","author":"Chefetz","year":"2008","journal-title":"J Invest Dermatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3569","article-title":"SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7","volume":"48","author":"Narumi","year":"2016","journal-title":"Nat Genet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1172\/JCI91913","article-title":"Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans","volume":"127","author":"Buonocore","year":"2017","journal-title":"J Clin Invest"},{"key":"B11","first-page":"1993","article-title":"MIRAGE syndrome","volume-title":"GeneReviews\u00ae","author":"Tanase-Nakao","year":"2020"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/cge.13914","article-title":"Achalasia as a symptom guide in MIRAGE syndrome: A novel case with p.R1293Q and p.R902W variants in the SAMD9 gene","volume":"99","author":"Baquedano-Lobera","year":"2021","journal-title":"Clin Genet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2021.742495","article-title":"MIRAGE syndrome caused by a de novo c.3406G>C (p. Glu1136Gln) mutation in the SAMD9 gene presenting with neonatal adrenal insufficiency and recurrent intussusception: A case report","author":"Chin","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12882-020-02011-4","article-title":"A girl with MIRAGE syndrome who developed steroid-resistant nephrotic syndrome: A case report","volume":"21","author":"Ishiwa","year":"2020","journal-title":"BMC Nephrol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017012682","article-title":"Poor outcome with hematopoietic stem cell transplantation for bone marrow failure and MDS with severe MIRAGE syndrome phenotype","volume":"2","author":"Sarthy","year":"2018","journal-title":"Blood Adv"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2020.06.002","article-title":"Evolution of histomorphologic, cytogenetic, and genetic abnormalities in an untreated patient with MIRAGE syndrome","volume":"245","author":"Rentas","year":"2020","journal-title":"Cancer Genet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1297\/cpe.28.147","article-title":"MIRAGE syndrome with recurrent pneumonia probably associated with gastroesophageal reflux and achalasia: A case report","volume":"28","author":"Yoshizaki","year":"2019","journal-title":"Clin Pediatr Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2017-105020","article-title":"Two patients with MIRAGE syndrome lacking haematological features: Role of somatic second-site reversion SAMD9 mutations","volume":"55","author":"Shima","year":"2018","journal-title":"J Med Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/0009922819832034","article-title":"Refractory infantile chronic diarrhea and failure to thrive in a 6-month-old boy with a complex past medical history","volume":"58","author":"Okafor","year":"2019","journal-title":"Clin Pediatr (Phila)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00625","article-title":"Reversion SAMD9 mutations modifying phenotypic expression of MIRAGE syndrome and allowing inheritance in a usually de novo disorder","volume":"10","author":"Roucher-Boulez","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/ICO.0000000000002900","article-title":"Lacrimal gland hypoplasia and corneal anesthesia in MIRAGE syndrome","author":"Basilious","year":"2021","journal-title":"Cornea"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206184","article-title":"MIRAGE syndrome is a rare cause of 46,XY DSD born SGA without adrenal insufficiency","volume":"13","author":"Shima","year":"2018","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.142","article-title":"Germline SAMD9 mutation in siblings with monosomy 7 and myelodysplastic syndrome","volume":"31","author":"Schwartz","year":"2017","journal-title":"Leukemia"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26747","article-title":"Comment on: Acquired monosomy 7 myelodysplastic syndrome in a child with clinical features of dyskeratosis congenita and IMAGe association","volume":"65","author":"Wilson","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.38557","article-title":"A novel SAMD9 mutation causing MIRAGE syndrome: An expansion and review of phenotype, dysmorphology, and natural history","volume":"176","author":"Jeffries","year":"2018","journal-title":"Am J Med Genet Part A"},{"key":"B26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12881-018-0546-4","article-title":"A case of an infant suspected as IMAGE syndrome who were finally diagnosed with MIRAGE syndrome by targeted mendelian exome sequencing","volume":"19","author":"Kim","year":"2018","journal-title":"BMC Med Genet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27589","article-title":"Somatic mosaic monosomy 7 and UPD7q in a child with MIRAGE syndrome caused by a novel SAMD9 mutation","volume":"66","author":"Csillag","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27726","article-title":"A novel SAMD9 variant identified in patient with MIRAGE syndrome: Further defining syndromic phenotype and review of previous cases","volume":"66","author":"Perisa","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/J.BBMT.2019.07.007","article-title":"Outcomes of hematopoietic cell transplantation in patients with germline SAMD9\/SAMD9L mutations","volume":"25","author":"Ahmed","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02194","article-title":"Novel SAMD9 mutation in a patient with immunodeficiency, neutropenia, impaired anti-CMV response, and severe gastrointestinal involvement","volume":"10","author":"Formankova","year":"2019","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12887-019-1733-y","article-title":"Mutations in both SAMD9 and SLC19A2 genes caused complex phenotypes characterized by recurrent infection, dysphagia and profound deafness \u2013 a case report for dual diagnosis","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Pediatr"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.galenos.2019.2019.0053","article-title":"A rare etiology of 46,XY disorder of sex development and adrenal insufficiency: A case of MIRAGE syndrome caused by mutations in the SAMD9 gene","volume":"12","author":"Mengen","year":"2020","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nlaa009","article-title":"The neuropathology of MIRAGE syndrome","volume":"79","author":"Viaene","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41439-020-0091-5","article-title":"MIRAGE syndrome caused by a novel missense variant (p.Ala1479Ser) in the SAMD9 gene","volume":"7","author":"Onuma","year":"2020","journal-title":"Hum Genome Var"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1297\/CPE.30.163","article-title":"Acquired uniparental disomy of chromosome 7 in a patient with MIRAGE syndrome that veiled a pathogenic SAMD9 variant","volume":"30","author":"Tanase-Nakao","year":"2021","journal-title":"Clin Pediatr Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41439-021-00158-6","article-title":"The case of a patient with MIRAGE syndrome with familial dysautonomia-like symptoms","volume":"8","author":"Kawashima-Sonoyama","year":"2021","journal-title":"Hum Genome Var"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01511-6","article-title":"Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9\/SAMD9L syndromes","volume":"27","author":"Sahoo","year":"2021","journal-title":"Nat Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00964-7","article-title":"Clinical and immunological analyses of ten patients with MIRAGE syndrome","volume":"41","author":"Mitsui-Sekinaka","year":"2021","journal-title":"J Clin Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.17605\/OSF.IO\/WMVXY","article-title":"Data from: Emerging phenotypes linked to variants in SAMD9 and MIRAGE syndrome","author":"Suntharalingham","year":"2022","journal-title":"Open Sci Framework"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2016.08.085","article-title":"A new biological and clinical resource for research into pregnancy complications: The baby bio bank","volume":"46","author":"Leon","year":"2016","journal-title":"Placenta"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2004.03.002","article-title":"Intrauterine growth restriction\u2013genetic causes and consequences","volume":"9","author":"Monk","year":"2004","journal-title":"Semin Fetal Neonatal Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003070","article-title":"Clinical management guidelines for obstetrician \u2013 gynecologists","volume":"133","year":"2020","journal-title":"Obstet Gynecol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2016.138","article-title":"Diagnosis and management of silver\u2013Russell syndrome: first international consensus statement","volume":"13","author":"Wakeling","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01843","article-title":"Genetic analyses in small-for-gestational-age newborns","volume":"103","author":"Stalman","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B45","doi-asserted-by":"publisher","first-page":"90","DOI":"10.12688\/f1000research.15016.2","article-title":"Analysis of CDKN1C in fetal growth restriction and pregnancy loss","volume":"8","author":"Suntharalingham","year":"2020","journal-title":"F1000Research"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3250","article-title":"Rare causes of primary adrenal insufficiency: genetic and clinical characterization of a large nationwide cohort","volume":"101","author":"Guran","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nat"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419","article-title":"Proteomics. tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Sci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0698-6","article-title":"Single-cell reconstruction of the early maternal\u2013fetal interface in humans","volume":"563","author":"Vento-Tormo","year":"2018","journal-title":"Nat"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.52004","article-title":"Single cell transcriptional signatures of the human placenta in term and preterm parturition","volume":"8","author":"Pique-Regi","year":"2019","journal-title":"Elife"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2009.6","article-title":"DOG 1.0: illustrator of protein domain structures","volume":"19","author":"Ren","year":"2009","journal-title":"Cell Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.2196\/16204","article-title":"PediTools electronic growth chart calculators: Applications in clinical care, research, and quality improvement","volume":"22","author":"Chou","year":"2020","journal-title":"J Med Internet Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.2116550119","article-title":"Structure and function of an effector domain in antiviral factors and tumor suppressors SAMD9 and SAMD9L","volume":"119","author":"Peng","year":"2022","journal-title":"Proc Natl Acad Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1210\/JCEM.84.12.6186","article-title":"IMAGe, a new clinical association of intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies","volume":"84","author":"Vilain","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2275","article-title":"Mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndrome","volume":"44","author":"Arboleda","year":"2012","journal-title":"Nat Genet"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2018.10.024","article-title":"DNA Polymerase epsilon deficiency causes IMAGe syndrome with variable immunodeficiency","volume":"103","author":"Logan","year":"2018","journal-title":"Am J Hum Genet"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/jendso\/bvab086","article-title":"Genetic analysis of pediatric primary adrenal insufficiency of unknown etiology: 25 years\u2019 experience in the UK","volume":"5","author":"Buonocore","year":"2021","journal-title":"J Endocr Soc"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.953707\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T06:09:46Z","timestamp":1660802986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.953707\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,18]]},"references-count":57,"alternative-id":["10.3389\/fendo.2022.953707"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.953707","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,18]]},"article-number":"953707"}}